Identity
- Trade Name
- Site~Rite 8 Ultrasound System FDA UDI
- Generic Name
- Ultrasound imaging system operator console FDA UDI
- Device Name
- Site~Rite 8 Ultrasound System Console (Remanufactured) FDA UDI
- Model / Reference
- 9770600Y FDA UDI
- Description
- Site~Rite 8 Ultrasound System Console (Remanufactured) FDA UDI
Identifiers
- Catalog Number
- 9770600Y FDA UDI
- Primary DI / UDI-DI
- 00801741138287 FDA UDI
- FDA Product Code
- IYO FDA UDILLZ FDA UDI
- GMDN Term
- Ultrasound imaging system operator console FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 892.1560 FDA UDI892.2050 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Ultrasound imaging system operator console
Site~Rite 8 Ultrasound System by Bard Access Systems, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Ultrasound imaging system operator console.
- Focalist System — Mendaera, Inc. · Class II
- Dermascan C Ver. 3 USB — Cortex Technology ApS · Class II
- Morpheus — PROMETHEUS GROUP OF NEW HAMPSHIRE LIMITED, THE · Class II
- SpineUs System — Verdure Imaging · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bard Access Systems, Inc.
Sources (1)
- FDA UDI cd784dd4-54cf-4347-800f-2d1757c816ee 35 fields · synced Jun 9, 2026